On Tuesday, Stifel analysts adjusted their outlook on ResMed (NYSE: RMD), a company specializing in medical equipment for treating sleep disorders, by reducing its price target to $240 from the ...

By offering discounted prices on ResMed’s top CPAP machines, we’re helping make sleep therapy accessible to more people, and that means more Canadians can experience the profound health ...

ResMed may have ... s take—its stock price has plummeted to lows not seen since 2021 before competitor Philips began its wide-ranging recall of CPAP and BiPAP machines and other respiratory ...

On Tuesday, Stifel analysts adjusted their outlook on ResMed (NYSE: RMD), a company specializing in medical equipment for treating sleep disorders, by reducing its price target to $240 from the ...